Sector
Country
Publishers
Publication Date

All

Your search criteria

>> Publisher: Informa
1 - 10 of 189
Wearables are Transforming R&D and Care Delivery June-2016
From USD 5000

Wearables are Transforming R&D and Care Delivery

Aerospace & Defense Report in Global

Industry Report

Wearables encompass the growing range of gadgets that can be attached to the body to measure certain physiological parameters. They are rapidly being adopted in healthcare, as part of a broader health IT revolution, with significant consequences for pharma in both the economics and execution of R&D. There are already an estimated 300 trials underway involving wearables, according to National Institutes of Health data reported in late 2015. Wearables’ most immediate potential is in chronic dis...

Download Sample Preview Sample
Agrow Crop Protection Markets in Africa 2016 April-2016
From USD 3205

Agrow Crop Protection Markets in Africa 2016

Agribusiness Report in

Industry Report

This comprehensive report covers the crop protection industry and value chain in Africa – for Fungicides, Herbicides, Insecticides, Plant Growth regulators, and Biopesticides. All 16 countries covered have distributor-level sales of US$20 million or more, with more in-depth profiles given for Egypt, Morocco, Cṑte d’Ivoire, Ghana, Kenya, and South Africa, which have crop protection markets each valued in excess of $50 million, and together represent approximately 60% of the African market. C...

Download Sample Preview Sample
FERTECON Biofertilizers 2016 April-2016
From USD 10500

FERTECON Biofertilizers 2016

Agribusiness Report in

Industry Report

This new Fertecon report fully covers the main types of biofertilizers – nitrogen fixers; phosphate solubilizers and mobilizers. The global inoculant companies, markets, sales and distribution channels are copiously detailed for this fast-growing segment, especially for Brazil; Argentina; the United States; and Asia. The report further covers the main advantages and benefits of biofertilizers, research & development; formulation; and the current regulatory situation.

Download Sample Preview Sample
Animal Pharm Phosphates for Animal Feed and Nutrition 2016 April-2016
From USD 2350

Animal Pharm Phosphates for Animal Feed and Nutrition 2016

Agribusiness Report in

Industry Report

The use of phosphates plays an increasingly strategic and fast-growing role in animal feed and nutrition, particularly in China and other emerging markets, where meat and livestock consumption is rising on economic growth and demand from the middle classes. This report focuses on the differing nutrient requirements of poultry, swine and cattle, and how phosphates are seen as increasingly essential to animal health vitality and development. The author also covers world phosphate resources, l...

Download Sample Preview Sample
Agrow Plant Stress Products 2016 April-2016
From USD 3205

Agrow Plant Stress Products 2016

Agribusiness Report in

Industry Report

Abiotic stresses such as heat, cold and drought prevent crops from reaching their full potential productivity. Plant stress products are a new category, increasing the tolerance of crop plants to these and other adverse environments. They span conventional pesticides with ‘crop enhancement’ or ‘plant health’ promoting properties, biostimulants and plant growth regulators. This updated report covers plant stress products from the categories of PGRs, fungicides, insecticides and biostimulants ...

Download Sample Preview Sample
Immuno-Oncology Deal Trends, 2011–15 March-2016
From USD 5000

Immuno-Oncology Deal Trends, 2011–15

Pharma Strategy Report in Global

Industry Report

Immuno-oncology is an emerging field in medicine that has the potential to radically change how cancer is treated. The Big Pharma and Mid Pharma peer sets are an integral part of development and have been furthering efforts via deal-making. The peer groups’ deal volume in immuno-oncology has grown over sevenfold from 2011 to 2015. More than 50% of the immuno-oncology deals between 2011 and 2015 involved testing combinations that may eventually address previously unresponsive patients and/or...

Download Sample Preview Sample
Big Pharma Licensing Trends, 2011–15 February-2016
From USD 5000

Big Pharma Licensing Trends, 2011–15

Pharma Strategy Report in Global

Industry Report

Key to predicting future trends in Big Pharma deal-making is reviewing the peer set’s most recent activity. Between 2011 and 2015, Big Pharma – a peer set of approximately 16 firms across the world with large R&D and sales organizations, and sales valued at $10bn or more – signed over 1,100 drug-focused deals, growing at a compound annual growth rate of 10%. Overall, Big Pharma represented the majority of the monetary value of all biopharma partnerships: the peer group was responsible for $13...

Download Sample Preview Sample
Pharma's Patient Centricity February-2016
From USD 5000

Pharma's Patient Centricity

Pharma Strategy Report in Global

Industry Report

Many in the industry agree that patient centricity is a business imperative, but it is unclear precisely what it means in business or organizational terms, and less clear still how to achieve it within the pharmaceutical industry. Patient centricity is not a function, but a mindset, a new way of doing R&D and of conceiving of therapeutic solutions. There are multiple forces driving greater patient centricity. These include payers’ focus on outcomes, the need for product differentiation, new ...

Download Sample Preview Sample
Animal Pharm -  Medicines for Aquaculture 2016 February-2016
From USD 2350

Animal Pharm - Medicines for Aquaculture 2016

Agribusiness Report in

Industry Report

The fast-growing aquaculture health industry is of increasing interest to the mainstream animal health sector. This is demonstrated by the entry and expansion of the big global players into this market i.e. MSD, Elanco and Zoetis among others. It is estimated to be worth around US$500 million already. This Animal Pharm report is the first to cover the aquaculture medicines market segment in depth. A wide range of diseases affect fish and shrimp production and these are described in the repor...

Download Sample Preview Sample
Atopic dermatitis: An increased focus on development of targeted therapies will address key unmet needs - Marketed Drugs, Pipeline, Forecast, Treatment and Epidemiology January-2016
From USD 20000

Atopic dermatitis: An increased focus on development of targeted therapies will address key unmet needs - Marketed Drugs, Pipeline, Forecast, Treatment and Epidemiology

Pharmaceuticals and Healthcare Report in

Company Report

Datamonitor Healthcare’s comprehensive atopic dermatitis report provides a 10-year patient based sales forecast, key prescribing information based on a survey of 216 dermatologists, marketed and pipeline profiles, and a 20-year epidemiology forecast. The reports covers key marketed therapies for atopic dermatitis, as well as analysis and forecasts for Phase III pipeline products. The report provides insight into how the market for atopic dermatitis will change over the next ten years, and how...

GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved